Contact
Mail
cccz@usz.ch
8th Zurich Immuno-Oncology Symposium
The 8th Zurich Immuno-Oncology Symposium will bring together clinicians and scientists from across the field of cancer immunotherapy to deepen the understanding of cancer, the immune system and immunotherapy.
Location
Grosser Hörsaal Path D22
University Hospital Zurich
Schmelzbergstrasse 12
8091 Zurich
Date
06.03.2024
Time
9 am - 5 pm
Credits
SGMO 6, SSRO 6
Program
This event will be held in English.
| 09.00 a.m. | Welcome Isabelle Schmitt-Opitz / Matthias Guckenberger, University Hospital Zurich |
|---|---|
| Session 1: Perioperative immunotherapy – Isabelle Schmitt-Opitz & Christian Gutschow | |
| 09.05 a.m. | Immunotherapy for everyone? Mastering the challenges of perioperative immunotherapy for lung cancer Brendon Stiles, Montefiore Health System, Albert Einstein College of Medicine, New York |
| 09.30 a.m. | ESOPEC and clinical trials on immunotherapy for colorectal cancer Christiane Bruns, University Hospital Cologne |
| 09.55 a.m. | Side effects of IT in the perioperative area Jordi Remon Masip, Gustave Roussy, Paris |
| 10.20 a.m. | Coffee break |
| Session 2: Oncology – Anja Lorch & Ralph Fritsch | |
| 10.45 a.m. | The microbiome to overcome resistance to cancer immunotherapies Michael Scharl, University Hospital Zurich |
| 11.10 a.m. | Renal cell cancer: Immuno-oncology 2024 and beyond Manuela Schmidinger, Medical University of Vienna |
| 11.35 a.m. | Targeting the immune desert – immunotherapy for pancreatic cancer Jens Siveke, University Hospital Essen |
| 12.00 p.m. | New immunotherapy approaches for melanoma Reinhard Dummer, University Hospital Zurich |
| 12.25 p.m. | Lunch |
| 1.10 p.m. | Welcome Director of University Medicine Zurich Beatrice Beck-Schimmer |
| Session 3: Optimal combination of radiotherapy and immunotherapy – what’s new? Panagiotis Balermpas & Matthias Guckenberger |
|
| 1.15 p.m. | Keynote lecture: Radiotherapy-immunotherapy combinations, current and future perspectives Silvia C. Formenti, Weill Cornell, New York |
| 1.40 p.m. | Challenges on the way to personalized radio-immunotherapy combination treatments Eric Deutsch, Gustave Roussy, Paris |
| 2.05 p.m. | Clinical implementation of the combination of immuno-radiotherapy using the example of head and neck cancer: How can synergies between the treatment modalities be optimized? Kevin Harrington, Royal Marsden, United Kingdom |
| 2.30 p.m. | Lymphatic sparing improves the response to radiotherapy Martin Pruschy, University Hospital Zurich |
| 2.55 p.m. | Coffee break |
| Session 4: Patrick Roth & Markus G. Manz | |
| 3.30 p.m. | Anti-angiogenic immunotherapy Arjan Griffioen, Amsterdam UMC |
| 3.55 p.m. | Overcoming exhaustion in cancer immunotherapy Alfred Zippelius, University of Basel |
| 4.20 p.m. | Neurological complications of cancer immunotherapy Antoine Carpentier, Paris |
| 4.45 p.m. | Conclusion Panagiotis Balermpas / Markus G. Manz, University Hospital Zurich |
